CATHERINE A MIRANDA
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MISSION VIEJO, CA NPI 1942547294
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA Acerta Pharma LLC All categories
General Payments — all program years on this page
$4,556.94
- Category: General Payments
- Program years: PY2021–2024
- Record count: 241
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,422.89 across 77 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,422.89 | 77 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $221.78 | 3 |
| PFIZER INC. | $174.89 | 17 |
| ABBVIE INC. | $171.72 | 14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.87 | 6 |
| Lilly USA, LLC | $135.04 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $116.29 | 5 |
| Novo Nordisk AS | $77.42 | 4 |
| Verity Pharmaceuticals Inc. | $61.15 | 3 |
| Amgen Inc. | $55.72 | 3 |
| Almatica Pharma Inc. | $46.16 | 3 |
| Astellas Pharma US Inc | $41.14 | 2 |
| SANOFI-AVENTIS U.S. LLC | $36.56 | 2 |
| Exact Sciences Corporation | $31.44 | 2 |
| Otsuka America Pharmaceutical, Inc. | $26.46 | 1 |
| Gilead Sciences, Inc. | $25.12 | 1 |
| Janssen Pharmaceuticals, Inc | $23.65 | 1 |
| Bausch Health US, LLC | $22.75 | 1 |
| Merck Sharp & Dohme Corporation | $14.73 | 1 |
By program year
Records — PY2024 (77)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.